NARSAD Grantees Elisabeth B. Binder, M.D., Ph.D. of Emory University and the Max-Planck Institute for Psychiatry and Kerry J. Ressler, M.D., Ph.D., Emory University and their team found differences in genetic expression...
Discoveries
Elisabeth B. Binder, M.D., Ph.D.
May 03, 2013
Akira Sawa, M.D., Ph.D.
May 02, 2013
Schizophrenia, an illness estimated to affect 1 in 100 American adults annually, is both debilitating and difficult to diagnose. Psychiatric clinical evaluations based on behavioral symptoms have been the only way to...
Scott A. Schobel, M.D.
April 29, 2013
A diagnosis of schizophrenia is often preceded by a "prodromal" phase of the illness, in which milder symptoms are present for weeks or even years before developing into full-blown psychosis. With the use of brain imaging...
Greer Murphy, M.D, Ph.D.
April 25, 2013
NARSAD Grantee, Greer Murphy, M.D, Ph.D., was among a team of researchers from the Stanford University School of Medicine who recently identified genetic variants encoding a protein secreted in the brain that impaired the...
Jonathan Mill, Ph.D
April 23, 2013
In the largest study of its kind to date, NARSAD Grant-supported researcher Jonathan Mill, Ph.D., of King's College London and the University of Exeter, and team studied 100 identical twins, including some with autism...
Pages
